Qingdao Baheal Pharmaceutical Holdings Limited’s Net Profit Rose 12.5% in First Half of 2022

Qingdao Baheal Pharmaceutical Holdings Limited (青岛百洋医药股份有限公司) (301015.SZ) reported a net profit of 209 million yuan in the first half of 2022, up 12.5% year-on-year.

Meanwhile, the company posted 3.7 billion yuan in revenue, up 11.5% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 2.5 billion yuan in total liabilities, with a liability-to-asset ratio of 55.2%.